213 related articles for article (PubMed ID: 24369092)
1. Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr Prison, Iran.
Asl RT; Eshrati B; Dell CA; Taylor K; Afshar P; Kamali M; Mirzazadeh A
Harm Reduct J; 2013 Dec; 10():41. PubMed ID: 24369092
[TBL] [Abstract][Full Text] [Related]
2. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.
Alipour A; Haghdoost AA; Sajadi L; Zolala F
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii41-4. PubMed ID: 24064986
[TBL] [Abstract][Full Text] [Related]
3. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.
Navadeh S; Mirzazadeh A; Gouya MM; Farnia M; Alasvand R; Haghdoost AA
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii33-6. PubMed ID: 23986417
[TBL] [Abstract][Full Text] [Related]
4. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
Quan VM; Go VF; Nam le V; Bergenstrom A; Thuoc NP; Zenilman J; Latkin C; Celentano DD
AIDS Care; 2009 Jan; 21(1):7-16. PubMed ID: 19085215
[TBL] [Abstract][Full Text] [Related]
5. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
[TBL] [Abstract][Full Text] [Related]
6. Reducing substance use and risky sexual behaviour among drug users in Durban, South Africa: Assessing the impact of community-level risk-reduction interventions.
Parry CDH; Carney T; Petersen Williams P
SAHARA J; 2017 Dec; 14(1):110-117. PubMed ID: 28969490
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M
Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
[TBL] [Abstract][Full Text] [Related]
8. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran.
Ramezani A; Amirmoezi R; Volk JE; Aghakhani A; Zarinfar N; McFarland W; Banifazl M; Mostafavi E; Eslamifar A; Sofian M
AIDS Care; 2014; 26(9):1122-6. PubMed ID: 24499303
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
Imani R; Karimi A; Rouzbahani R; Rouzbahani A
East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
[TBL] [Abstract][Full Text] [Related]
10. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
11. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
[TBL] [Abstract][Full Text] [Related]
12. HIV testing among incarcerated people with a history of HIV-related high-risk behaviours in Iran: Findings from three consecutive national bio-behavioural surveys.
Tavakoli F; Parhizgari N; Shokoohi M; Khezri M; Haghdoost AA; Ghasemzadeh I; Bozicevic I; Shahesmaeili A; Nasiri N; Danesh A; Karamouzian M; Sharifi H
BMC Infect Dis; 2022 Dec; 22(1):907. PubMed ID: 36471282
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons.
O'Sullivan BG; Levy MH; Dolan KA; Post JJ; Barton SG; Dwyer DE; Kaldor JM; Grulich AE
Med J Aust; 2003 Jun; 178(11):546-9. PubMed ID: 12765501
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
[TBL] [Abstract][Full Text] [Related]
15. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut.
Grau LE; Zhan W; Heimer R
Drug Alcohol Rev; 2016 Sep; 35(5):628-36. PubMed ID: 27073014
[TBL] [Abstract][Full Text] [Related]
16. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
Weiss SH; Weston CB; Quirinale J
AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
[TBL] [Abstract][Full Text] [Related]
17. A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany.
Stark K; Herrmann U; Ehrhardt S; Bienzle U
Epidemiol Infect; 2006 Aug; 134(4):814-9. PubMed ID: 16371183
[TBL] [Abstract][Full Text] [Related]
18. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study.
Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S
BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.
Van Ameijden EJ; Van den Hoek JA; Mientjes GH; Coutinho RA
Eur J Epidemiol; 1993 May; 9(3):255-62. PubMed ID: 8405310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
